Bio-Techne Corp: updates and filings

TECHNASDAQHealthcare · Biological Products, (No Diagnostic Substances)

Price

$72.80

November 13, 2026Market cap $11.4B

DCF calculator

What Ploutos Investor adds for Bio-Techne

Part of Ploutos Investor, €9.99 a month

See the plans

The full history: 17 fiscal years, from FY2010
The estimated fair value, with its range and its certainty
The full analysis, 18 a month
More questions to the chat on its filings
Excel with every year
An email when it reports, changes its dividend or an officer buys

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Next results

in 82 daysAround Feb 5, 2027 · for Q2 2027

last Aug 12, 2026next Feb 5, 2027

An estimate from when it has reported before, which has been regular. The company announces the date itself.

November 2026

September 2026

August 2026

June 2026

26FriDealMaterial agreement entered, officer or director changeDocument

May 2026

February 2026

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Aug 24, 2026 latest annualNov 6, 2026 latest quarterly

Nov 12, 2026Quarterly report (amendment)for the period to Sep 30, 2026
Form10-Q/A
Nov 6, 2026Quarterly reportfor the period to Sep 30, 2026
Form10-Q
Nov 5, 2026Over-5% holder statement (passive) (amendment)
FormSCHEDULE 13G/A
Nov 4, 2026Other material events
Form8-K
Oct 28, 2026Annual report (amendment)for the period to Jun 30, 2026
Form10-K/A
Sep 23, 2026Shareholder vote, Regulation FD disclosure
Form8-K
Sep 14, 2026Additional annual meeting material
FormDEFA14A
Sep 14, 2026Other material events
Form8-K
Sep 9, 2026Additional annual meeting material
FormDEFA14A
Sep 2, 2026Additional annual meeting material
FormDEFA14A
Aug 25, 2026Additional annual meeting material
FormDEFA14A
Aug 24, 2026Annual reportfor the period to Jun 30, 2026
Form10-K
Aug 20, 2026Merger meeting proxy statement
FormDEFM14A
Aug 12, 2026Results of operations, other material events
Form8-K
Aug 10, 2026Filing
FormPREM14A
Aug 6, 2026Over-5% holder statement (passive) (amendment)
FormSCHEDULE 13G/A
Jul 9, 2026Additional annual meeting material
FormDEFA14A
Jun 26, 2026Material agreement entered, officer or director change
Form8-K
Jun 25, 2026Additional annual meeting material
FormDEFA14A
Jun 25, 2026Regulation FD disclosure
Form8-K
Jun 1, 2026Conflict minerals report
FormSD
May 6, 2026Quarterly reportfor the period to Mar 31, 2026
Form10-Q
May 6, 2026Over-5% holder statement (passive)
FormSCHEDULE 13G
May 6, 2026Results of operations, other material events
Form8-K
Apr 29, 2026Over-5% holder statement (passive)
FormSCHEDULE 13G

Filed	Form	What it is	Filing
Nov 12, 2026	10-Q/A	Quarterly report (amendment)for the period to Sep 30, 2026	Document
Nov 6, 2026	10-Q	Quarterly reportfor the period to Sep 30, 2026	Document
Nov 5, 2026	SCHEDULE 13G/A	Over-5% holder statement (passive) (amendment)	Document
Nov 4, 2026	8-K	Other material events	Document
Oct 28, 2026	10-K/A	Annual report (amendment)for the period to Jun 30, 2026	Document
Sep 23, 2026	8-K	Shareholder vote, Regulation FD disclosure	Document
Sep 14, 2026	DEFA14A	Additional annual meeting material	Document
Sep 14, 2026	8-K	Other material events	Document
Sep 9, 2026	DEFA14A	Additional annual meeting material	Document
Sep 2, 2026	DEFA14A	Additional annual meeting material	Document
Aug 25, 2026	DEFA14A	Additional annual meeting material	Document
Aug 24, 2026	10-K	Annual reportfor the period to Jun 30, 2026	Document
Aug 20, 2026	DEFM14A	Merger meeting proxy statement	Document
Aug 12, 2026	8-K	Results of operations, other material events	Document
Aug 10, 2026	PREM14A	Filing	Document
Aug 6, 2026	SCHEDULE 13G/A	Over-5% holder statement (passive) (amendment)	Document
Jul 9, 2026	DEFA14A	Additional annual meeting material	Document
Jun 26, 2026	8-K	Material agreement entered, officer or director change	Document
Jun 25, 2026	DEFA14A	Additional annual meeting material	Document
Jun 25, 2026	8-K	Regulation FD disclosure	Document
Jun 1, 2026	SD	Conflict minerals report	Document
May 6, 2026	10-Q	Quarterly reportfor the period to Mar 31, 2026	Document
May 6, 2026	SCHEDULE 13G	Over-5% holder statement (passive)	Document
May 6, 2026	8-K	Results of operations, other material events	Document
Apr 29, 2026	SCHEDULE 13G	Over-5% holder statement (passive)	Document

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since May 10, 1995.

And 708 filings on insiders' shares661 Form 4, 13 Form 144 and 27 Form 3 since May 14, 2003. Their trades are on the Ownership tab.

The full analysis

What do Bio-Techne's filings show?

The filings are where every one of Bio-Techne's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

A fair value range built from the filings
Earnings quality, debt and red flags
Insider and institutional moves
The case for and the case against

All filings on EDGAR

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

US stocksThe market today, the sectors, the largest companies and the week's results.The market's sectorsThe 11 sectors side by side: returns, share of the market, median P/E and dividend.Compare stocksTwo companies side by side: price over up to ten years, with and without dividends, and every figure.US dividend stocksEach dividend's yield next to whether the company's cash covers it and whether it was ever cut.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.